By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) Biotech Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer 1/17/2017 6:58:00 AM
Tesaro (TSRO) Announces Priority Review Designation For Niraparib NDA 12/20/2016 8:56:39 AM
Tesaro (TSRO) Announces Participation In Three Investor Conferences 11/22/2016 7:57:51 AM
Tesaro (TSRO) Announces Proposed Public Offering Of Common Stock 11/14/2016 10:02:42 AM
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro (TSRO) and Sarepta (SRPT) 11/11/2016 5:56:11 AM
Tesaro (TSRO) Announces Third-Quarter 2016 Operating Results 11/4/2016 9:18:22 AM
Tesaro (TSRO) Announces Submission Of Niraparib New Drug Application For Platinum-Sensitive, Recurrent Ovarian Cancer 11/2/2016 9:03:02 AM
Tesaro (TSRO) Announces Presentation Of Niraparib Data At The 2016 IGCS Biennial Meeting 10/31/2016 9:14:55 AM
Tesaro (TSRO) Announces Acceptance For Review Of Niraparib Marketing Authorization Application By EMA 10/28/2016 8:55:36 AM
AstraZeneca PLC (AZN) Is Now A Competitive Threat To Tesaro (TSRO) In Ovarian Cancer Maintenance Therapy 10/26/2016 7:25:59 AM